SECsense Logo

Protagonist Therapeutics, Inc. 8-K Report: Key Insights & Financial Snapshot

$PTGX
Form 8-K
Filed on: 2025-01-06
Source
Protagonist Therapeutics, Inc. 8-K Report: Key Insights & Financial Snapshot

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Protagonist Therapeutics, Inc.
  • Incorporation: Delaware (DE)
  • CIK: 0001377121
  • SEC Central Index Key (CIK): 0001377121
  • Address: 7707 Gateway Blvd., Suite 140, Newark, CA 94560-1160
  • Phone Number: 510-474-0170
  1. Filing Type:
  • Document Type: 8-K
  • Filing Date: January 1, 2025
  1. Stock Information:
  • Common Stock: Par value of $0.00001
  • Ticker Symbol: PTGX
  • Exchange: NASDAQ
  1. Reporting Period:
  • As of Date: January 1, 2025
  • Period Start and End Date: January 1, 2025
  1. Financial Measurements:
  • Currency: US Dollars (USD)
  • Unit of Measurement: Shares
  1. Other Notable Information:
  • The filing is structured in XBRL format, which is used for reporting financial data and is compliant with SEC regulations.

This information provides a snapshot of Protagonist Therapeutics, Inc.'s current status as of the report date, including its market position and operational details.